Stock Based Compensation	3 Months Ended
Mar. 27, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Based Compensation	8. Stock Based Compensation During the three months ended March 27, 2020, the Company issued 556,604 restricted stock units at a weighted average grant-date fair value of $15.77 per share. As of March 27, 2020, the Company had 1,183,539 restricted stock units outstanding at a weighted average grant-date fair value of $16.75 per share. As of March 27, 2020, $17.0 million of total restricted stock unit compensation expense related to unvested awards had not been recognized and is expected to be recognized over a weighted average period of approximately 2.6 years. As of March 27, 2020, the Company had 127,738 shares of common stock subject to vesting requirements outstanding at a weighted average grant-date fair value of $18.65 per share. As of March 27, 2020, $1.3 million of compensation expense related to common stock subject to vesting requirements had not been recognized and is expected to be recognized over a weighted average period of approximately 1.4 years. Forfeitures for all of the Company’s outstanding equity are recognized as incurred.

Stock Based Compensation

3 Months Ended

Mar. 27, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

8. Stock Based Compensation

During the three months ended March 27, 2020, the Company issued 556,604 restricted stock units at a weighted average grant-date fair value of $15.77 per share. As of March 27, 2020, the Company had 1,183,539 restricted stock units outstanding at a weighted average grant-date fair value of $16.75 per share. As of March 27, 2020, $17.0 million of total restricted stock unit compensation expense related to unvested awards had not been recognized and is expected to be recognized over a weighted average period of approximately 2.6 years.

As of March 27, 2020, the Company had 127,738 shares of common stock subject to vesting requirements outstanding at a weighted average grant-date fair value of $18.65 per share. As of March 27, 2020, $1.3 million of compensation expense related to common stock subject to vesting requirements had not been recognized and is expected to be recognized over a weighted average period of approximately 1.4 years.

Forfeitures for all of the Company’s outstanding equity are recognized as incurred.